These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 22665077

  • 1. Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species.
    He F, Wang Q, Zheng XL, Yan JQ, Yang L, Sun H, Hu LN, Lin Y, Wang X.
    Oncol Rep; 2012 Aug; 28(2):601-5. PubMed ID: 22665077
    [Abstract] [Full Text] [Related]

  • 2. Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins.
    Yang L, Wang Q, Li D, Zhou Y, Zheng X, Sun H, Yan J, Zhang L, Lin Y, Wang X.
    Apoptosis; 2013 May; 18(5):618-26. PubMed ID: 23371323
    [Abstract] [Full Text] [Related]

  • 3. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
    Kim EH, Jang H, Shin D, Baek SH, Roh JL.
    Apoptosis; 2016 Nov; 21(11):1265-1278. PubMed ID: 27544755
    [Abstract] [Full Text] [Related]

  • 4. Catalase suppression-mediated H(2)O(2) accumulation in cancer cells by wogonin effectively blocks tumor necrosis factor-induced NF-κB activation and sensitizes apoptosis.
    Yang L, Zheng XL, Sun H, Zhong YJ, Wang Q, He HN, Shi XW, Zhou B, Li JK, Lin Y, Zhang L, Wang X.
    Cancer Sci; 2011 Apr; 102(4):870-6. PubMed ID: 21244577
    [Abstract] [Full Text] [Related]

  • 5. Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells.
    Wang Q, Zheng XL, Yang L, Shi F, Gao LB, Zhong YJ, Sun H, He F, Lin Y, Wang X.
    J Exp Clin Cancer Res; 2010 Dec 09; 29(1):159. PubMed ID: 21143894
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Wogonin, a plant flavone, potentiates etoposide-induced apoptosis in cancer cells.
    Lee E, Enomoto R, Suzuki C, Ohno M, Ohashi T, Miyauchi A, Tanimoto E, Maeda K, Hirano H, Yokoi T, Sugahara C.
    Ann N Y Acad Sci; 2007 Jan 09; 1095():521-6. PubMed ID: 17404065
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects.
    Enomoto R, Koshiba C, Suzuki C, Lee E.
    Cancer Chemother Pharmacol; 2011 May 09; 67(5):1063-72. PubMed ID: 20658136
    [Abstract] [Full Text] [Related]

  • 10. Reactive oxygen species up-regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin.
    Lee DH, Rhee JG, Lee YJ.
    Br J Pharmacol; 2009 Aug 09; 157(7):1189-202. PubMed ID: 19438509
    [Abstract] [Full Text] [Related]

  • 11. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z, Zeng Q, Zhang B, Liu H, Wang W.
    Biochimie; 2014 Dec 09; 107 Pt B():257-62. PubMed ID: 25220870
    [Abstract] [Full Text] [Related]

  • 12. Wogonin triggers apoptosis in human osteosarcoma U-2 OS cells through the endoplasmic reticulum stress, mitochondrial dysfunction and caspase-3-dependent signaling pathways.
    Lin CC, Kuo CL, Lee MH, Lai KC, Lin JP, Yang JS, Yu CS, Lu CC, Chiang JH, Chueh FS, Chung JG.
    Int J Oncol; 2011 Jul 09; 39(1):217-24. PubMed ID: 21573491
    [Abstract] [Full Text] [Related]

  • 13. Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells.
    Kim MS, Bak Y, Park YS, Lee DH, Kim JH, Kang JW, Song HH, Oh SR, Yoon DY.
    Cell Biol Toxicol; 2013 Aug 09; 29(4):259-72. PubMed ID: 23955116
    [Abstract] [Full Text] [Related]

  • 14. [Recombinant soluble CD40 ligand enhances Wogonin-induced antitumor activity].
    Zhou YQ, Li DX, Zheng XL, Yan YY, Lin Y, Wang X, Liao LC.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov 09; 44(6):859-64. PubMed ID: 24490490
    [Abstract] [Full Text] [Related]

  • 15. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI, Kim JH, Lee KT, Choi JH.
    Gynecol Oncol; 2011 Dec 09; 123(3):588-96. PubMed ID: 21945308
    [Abstract] [Full Text] [Related]

  • 16. Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling in HepG2 cells.
    Qian C, Wang Y, Zhong Y, Tang J, Zhang J, Li Z, Wang Q, Hu R.
    Free Radic Res; 2014 May 09; 48(5):607-21. PubMed ID: 24666416
    [Abstract] [Full Text] [Related]

  • 17. Wogonin Increases Cisplatin Sensitivity in Ovarian Cancer Cells Through Inhibition of the Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway.
    Xing F, Sun C, Luo N, He Y, Chen M, Ding S, Liu C, Feng L, Cheng Z.
    Med Sci Monit; 2019 Aug 12; 25():6007-6014. PubMed ID: 31402794
    [Abstract] [Full Text] [Related]

  • 18. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment.
    Gatti L, Cossa G, Tinelli S, Carenini N, Arrighetti N, Pennati M, Cominetti D, De Cesare M, Zunino F, Zaffaroni N, Perego P.
    J Pharmacol Exp Ther; 2014 Mar 12; 348(3):360-71. PubMed ID: 24345465
    [Abstract] [Full Text] [Related]

  • 19. Wogonin induces apoptosis by activation of ERK and p38 MAPKs signaling pathways and generation of reactive oxygen species in human breast cancer cells.
    Yu JS, Kim AK.
    Mol Cells; 2011 Apr 12; 31(4):327-35. PubMed ID: 21448585
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
    Wu XX, Kakehi Y.
    Clin Cancer Res; 2009 Mar 15; 15(6):2039-47. PubMed ID: 19276256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.